{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T12:39:38Z","timestamp":1722515978318},"reference-count":20,"publisher":"Elsevier","isbn-type":[{"value":"9780128132579","type":"print"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/b978-0-12-813257-9.00026-7","type":"book-chapter","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T13:31:33Z","timestamp":1595597493000},"page":"449-461","source":"Crossref","is-referenced-by-count":1,"title":["Molecular biology of breast cancer"],"prefix":"10.1016","author":[{"given":"Mariana","family":"Brand\u00e3o","sequence":"first","affiliation":[]},{"given":"Philippe","family":"Aftimos","sequence":"additional","affiliation":[]},{"suffix":"Jr.","given":"Hatem A.","family":"Azim","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Sotiriou","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur1","series-title":"World Health Organization classification of tumours of the breast","author":"Lakhani","year":"2012"},{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur2","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1200\/JCO.2007.11.9453","article-title":"Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1\u201398","volume":"25","author":"Viale","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur3","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur4","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update","volume":"36","author":"Wolff","year":"2018","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/B978-0-12-813257-9.00026-7_fur5","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1200\/JCO.2015.65.2289","article-title":"Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: American Society of Clinical Oncology practice guideline","volume":"34","author":"Harris","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur6","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJMoa052306","article-title":"Herceptin adjuvant (HERA) trial study Team trastuzumab after adjuvant chemotherapy HER2-positive breast cancer","volume":"353","author":"Piccart-Gebhart","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur7","doi-asserted-by":"crossref","first-page":"e0157368","DOI":"10.1371\/journal.pone.0157368","article-title":"Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection","volume":"11","author":"Lehmann","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"Denkert","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs working group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrclinonc.2017.96","article-title":"HER2-positive breast cancer is lost in translation: time for patient-centered research","volume":"14","author":"Gingras","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11017","article-title":"The landscape of cancer genes and mutational processes in breast cancer","volume":"486","author":"Stephens","year":"2012","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"METABRIC group, the genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMra0801289","article-title":"Gene-expression signatures in breast cancer","volume":"360","author":"Sotiriou","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene signature as an aid to treatment decisions in early-stage breast cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/jamaoncol.2017.5524","article-title":"Comparison of the performance of 6 prognostic signatures for estrogen receptor-positive breast cancer: a secondary analysis of a randomized clinical trial","volume":"4","author":"Sestak","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur18","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1158\/1078-0432.CCR-07-4756","article-title":"Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes","volume":"14","author":"Desmedt","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur19","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1200\/JCO.2015.64.0334","article-title":"Genomic characterization of primary invasive lobular breast cancer","volume":"34","author":"Desmedt","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/B978-0-12-813257-9.00026-7_fur20","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa1213261","article-title":"Analysis of circulating tumor DNA to monitor metastatic breast cancer","volume":"368","author":"Dawson","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Essential Concepts in Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128132579000267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128132579000267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T13:31:40Z","timestamp":1595597500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128132579000267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780128132579"],"references-count":20,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-813257-9.00026-7","relation":{},"subject":[],"published":{"date-parts":[[2020]]}}}